Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanual Maverakis

Showing results (131-140 of 226) with videos related to

Pageof 23
Sort By:
The Journal of Investigative Dermatology|July 25, 2021
New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision MedicineDi Yan, Johann E Gudjonsson, Stephanie Le, et al.
Dermatology and Therapy|March 9, 2023
Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled TrialAlexa B Kimball, Errol P Prens, Thierry Passeron, et al.
Allergy|May 5, 2026
Lupus Panniculitis Immunoprofiling Reveals a Cytotoxic, Type 1-Skewed T-Cell Response With Signs of Metabolic AlterationMilad Ameri, Reihane Ziadlou, Stephan Traidl, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 17, 2021
Anti-Interleukin 23-Based Therapies May Shift Cutaneous Immune Responses: A Case of New-Onset Contact Dermatitis to Carbamates After Guselkumab for PsoriasisWilliam Liakos, Atrin Toussi, Stephanie T Le, et al.
The Journal of Experimental Medicine|October 15, 2003
The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cellsDirk Elewaut, Anna P Lawton, Niranjana A Nagarajan, et al.
International Wound Journal|June 3, 2019
End stage scurvy in the developed world: A diagnostic conundrum but not to be mistaken for pyoderma gangrenosumStephanie T Le, Jenny Z Wang, Claire C Alexanian, et al.
Science Advances|July 12, 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumorsNick R Love, Claire Williams, Emily E Killingbeck, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|September 18, 2018
Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled TrialAdam R Ford, Caitlin M Gibbons, Josefina Torres, et al.
Plos One|November 8, 2012
Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responsesMyriam N Bouchlaka, Gail D Sckisel, Danice Wilkins, et al.
RSC Advances|July 8, 2022
Quantitative glycoproteomics of high-density lipoproteinsXinyu Tang, Maurice Wong, Jennyfer Tena, et al.
Pageof 23

Showing results (131-140 of 226) with videos related to

Sort By:
Pageof 23
The Journal of Investigative Dermatology|July 25, 2021
New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision MedicineDi Yan, Johann E Gudjonsson, Stephanie Le, et al.
Dermatology and Therapy|March 9, 2023
Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled TrialAlexa B Kimball, Errol P Prens, Thierry Passeron, et al.
Allergy|May 5, 2026
Lupus Panniculitis Immunoprofiling Reveals a Cytotoxic, Type 1-Skewed T-Cell Response With Signs of Metabolic AlterationMilad Ameri, Reihane Ziadlou, Stephan Traidl, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 17, 2021
Anti-Interleukin 23-Based Therapies May Shift Cutaneous Immune Responses: A Case of New-Onset Contact Dermatitis to Carbamates After Guselkumab for PsoriasisWilliam Liakos, Atrin Toussi, Stephanie T Le, et al.
The Journal of Experimental Medicine|October 15, 2003
The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cellsDirk Elewaut, Anna P Lawton, Niranjana A Nagarajan, et al.
International Wound Journal|June 3, 2019
End stage scurvy in the developed world: A diagnostic conundrum but not to be mistaken for pyoderma gangrenosumStephanie T Le, Jenny Z Wang, Claire C Alexanian, et al.
Science Advances|July 12, 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumorsNick R Love, Claire Williams, Emily E Killingbeck, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|September 18, 2018
Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled TrialAdam R Ford, Caitlin M Gibbons, Josefina Torres, et al.
Plos One|November 8, 2012
Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responsesMyriam N Bouchlaka, Gail D Sckisel, Danice Wilkins, et al.
RSC Advances|July 8, 2022
Quantitative glycoproteomics of high-density lipoproteinsXinyu Tang, Maurice Wong, Jennyfer Tena, et al.
Pageof 23